Evidence map›Paper›PMID 28465098›Full record

ArticleBioorganic & medicinal chemistry letters2017

Flex-nucleoside analogues - Novel therapeutics against filoviruses.

Mary K Yates, Mithun R Raje, Payel Chatterjee, Christina F Spiropoulou, Sina Bavari, Mike Flint, Veronica Soloveva, Katherine L Seley-Radtke

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Current Trends and Limitations in Dengue Antiviral Research.Tropical medicine and infectious disease · 2021
    Review
  6. Broad spectrum antiviral nucleosides-Our best hope for the future.Annual reports in medicinal chemistry · 2021
    Article
  7. Article
  8. New Metal-Free Route towards Imidazole-Substituted Uridine.European journal of organic chemistry · 2020
    Article
  9. Article
  10. Nucleoside Analogs with Fleximer Nucleobase.Chemistry of heterocyclic compounds · 2020
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Flexibility-Not just for yoga anymore!Antiviral chemistry & chemotherapy
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mary K YatesDepartment of Chemistry and Biochemistry, University of Maryland Baltimore County, Baltimore, MD 21250, United States.
Mithun R RajeDepartment of Chemistry and Biochemistry, University of Maryland Baltimore County, Baltimore, MD 21250, United States.
Payel ChatterjeeViral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, United States.
Christina F SpiropoulouViral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, United States.
Sina BavariUS Army Medical Research Institute, Frederick, MD 21702, United States.
Mike FlintViral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, United States.
Veronica SolovevaUS Army Medical Research Institute, Frederick, MD 21702, United States.
Katherine L Seley-RadtkeDepartment of Chemistry and Biochemistry, University of Maryland Baltimore County, Baltimore, MD 21250, United States. Electronic address: kseley@umbc.edu.

Funding

Graduate Training at The Chemistry Biology InterfaceT32GM066706 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI SELEY-RADTKE, KATHERINE L, SMITH, AARON T · 2004 to 2023
$3.3M
A Flexible Approach to Avoid Viral Escape MutationsR21AI097685 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI SELEY-RADTKE, KATHERINE L · 2012 to 2013
$417k
NIAID NIH HHS R21 AI097685NIGMS NIH HHS T32 GM066706
6 · The paper itself

Abstract

Fleximers, a novel type of flexible nucleoside that have garnered attention due to their unprecedented activity against human coronaviruses, have now exhibited highly promising levels of activity against filoviruses. The Flex-nucleoside was the most potent against recombinant Ebola virus in Huh7 cells with an EC

Indexed as

Antiviral AgentsCell LineDose-Response Relationship, DrugEbolavirusHumansMicrobial Sensitivity TestsMolecular StructureNucleosidesStructure-Activity RelationshipAntiviral AgentsNucleosidesAntiviralEbolaFilovirusFleximersNucleoside

Identifiers

PMID28465098
PMCPMC5626011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.